Diabetes

The majority of Medicare beneficiaries with insulin-treated diabetes are either not prescribed continuous blood glucose monitoring or do not use the technology as directed, according to study data.

In a new analysis of the pooled cohort of the two STOPDAPT-2 trials of patients who had PCI, clopidogrel monotherapy after 1 month of dual antiplatelet therapy was associated with reduced bleeding risk regardless of diabetes status.

Adults with elevated serum sodium in middle age, a marker of inadequate fluid intake, were more likely to be biologically older than their chronological age and develop chronic diseases compared with adequately hydrated adults, data show.

Researchers hypothesize that the number of youths in the U.S. with diabetes is likely to substantially increase in future decades, highlighting the need for diabetes prevention, according to estimates published in Diabetes Care.

Healio and Endocrine Today editors have compiled the top diabetes news from 2022.

Notable updates to the American Diabetes Association’s 2023 Standards of Care address the role of weight loss in diabetes management and cardiovascular risks and now advise lower targets for blood pressure and LDL cholesterol.

The American Heart Association Scientific Sessions were held Nov. 5 to 7 in Chicago, the first time they were conducted in-person since 2019.

The proportion of adults with diabetes in the U.S. achieving glycemic control was similar in 2013 to 2020 compared with 1988 to 1994, but racial-ethnic disparities worsened during that time, according to study data.

Adults with obesity, diabetes and hypertension have a higher prevalence of reduced eGFR, according to a study published in Kidney Medicine.